Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Pseudogout

From the College  |  Issue: July 2008  |  July 1, 2008

Pseudogout is a type of arthritis that, as the name implies, can cause symptoms similar to gout, but which are a reaction to a different type of crystal deposit. This type of arthritis may be one of the most misunderstood forms, and is often mistaken for gout and other conditions, including RA. Proper diagnosis is important because untreated pseudogout may lead to a severe form of joint degeneration and ongoing inflammation, resulting in chronic disability.

Pseudogout develops when deposits of calcium pyrophosphate crystals accumulate in a joint. Initially, crystals deposit in the cartilage and can cause damage. They also can cause a reaction with inflammation that leads to joint pain and swelling. This can cause more chronic arthritis that mimics osteoarthritis or RA. Knees are most often involved, but wrists, shoulders, ankles, elbows, and hands can be affected. Ultimately, a patient with pseudogout could be incapacitated for days or weeks.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Anyone can develop pseudogout, and the risk greatly increases with age. According to patient fact-sheet writer H. Ralph Schumacher, MD, “about 3% of people in their sixties, and as many as 50% of people in their nineties, show evidence of pseudogout crystal, though not all experience symptoms.”

To obtain a proper diagnosis for pseudogout, other potential causes of symptoms (such as gout, RA, or infection) must be ruled out. The diagnosis is made on the basis of symptoms and through medical tests, including using a needle to take fluid from the swollen or painful joint to determine whether calcium pyrophosphate crystals are present. An X-ray of the joint may also be taken to determine if calcium-containing deposits are present, creating a condition known as chondrocalcinosis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

It is not known how to prevent pseudogout. To treat it, patients may be prescribed nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin (Indocin) and naproxen (Naprosyn) to treat pain and disability. Low doses of colchicine or NSAIDs may prove effective to prevent further attacks. However, no treatment is available to dissolve the crystal deposits, and those with poor kidney function, a history of stomach ulcers, or on blood thinners often cannot take NSAIDs. These patients may find a cortisone shot into the affected joint helpful.

Download the complete pseudogout fact sheet and other patient education materials at www.rheumatology.org by following the links to patient education from the Practice Support Menu.

Share: 

Filed under:ConditionsFrom the CollegeGout and Crystalline Arthritis Tagged with:ClinicalDiagnostic CriteriaRA

Related Articles

    Research Reveals Clues Into Inflammatory Process of Crystal Arthropathies Note Experts at the 2013 ACR/ARHP Annual Meeting

    March 1, 2014

    New studies clarify the roles of monosodium urate crystals in gout, calcium pyrophosphate crystals in osteoarthritis, and identify more effective potential therapies for patients

    Clinical Applications of Dual-Energy Computed Tomography for Rheumatology

    June 1, 2014

    Advanced imaging technique allows physicians to detect deposition of monosodium urate crystals not apparent in physical exams and better diagnose gout

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    New Insights into CPPD

    October 1, 2013

    Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences